A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 18, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

July 31, 2027

Conditions

Still's Disease, Adult-Onset

Interventions

BIOLOGICAL

Firsekibart

Firsekibart will be administered according to the protocol

BIOLOGICAL

Anakinra

Anakinra will be administered according to the protocol

All Listed Sponsors

lead

Ruijin Hospital

OTHER